NORTHBROOK, Ill., May 13, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the “Company”) (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced the closing of its previously announced underwritten public offering of 15,686,000 shares of its common stock at a public offering price of $2.20 per share, including 2,046,000 shares of common stock issued pursuant to the underwriters’ exercise in full of their over-allotment option. Piper Jaffray & Co. acted as the sole book-running manager and Roth Capital Partners, LLC acted as co-manager for the offering.
